Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac Sodium

PHASE1CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

March 31, 2008

Conditions
Healthy
Interventions
DRUG

Intravenous diclofenac sodium (DIC075V)

High dose Diclofenac

DRUG

Intravenous diclofenac sodium (DIC075V)

Low Dose Diclofenac

Trial Locations (2)

21225

PAREXEL International, Baltimore

33025

Comprehensive Phase One, Miramar

Sponsors
All Listed Sponsors
lead

Javelin Pharmaceuticals

INDUSTRY